Authors:
Freyer, G
Ligneau, B
Schlumberger, M
Blandy, C
Contedevolx, B
Trillet-Lenoir, V
Lenoir, GM
Chau, N
Dazord, A
Citation: G. Freyer et al., Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: Trends for future evaluations, ANN ONCOL, 12(10), 2001, pp. 1461-1465
Authors:
Freyer, G
Bossard, N
Romestaing, P
Mornex, F
Chapet, O
Trillet-Lenoir, V
Gerard, JP
Citation: G. Freyer et al., Addition of oxaliplatin to continuous fluorouracil, L-folinic acid, and concomitant radiotherapy in rectal cancer: The Lyon R 97-03 Phase I trial, J CL ONCOL, 19(9), 2001, pp. 2433-2438
Authors:
Freyer, G
Ligneau, B
Tranchand, B
Ardiet, C
Souquet, PJ
Court-Fortune, I
Riou, R
Rebattu, P
Morignat, E
Boissel, JP
Trillet-Lenoir, V
Girard, P
Citation: G. Freyer et al., The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients: a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT), LUNG CANC, 31(2-3), 2001, pp. 247-256
Authors:
Dumortier, J
Freyer, G
Sasco, AJ
Frappart, L
Zenone, T
Romestaing, P
Trillet-Lenoir, V
Citation: J. Dumortier et al., Endometrial mesodermal mixed tumor occurring after tamoxifen treatment: Report on a new case and review of the literature, ANN ONCOL, 11(3), 2000, pp. 355-358
Authors:
de Gramont, A
Figer, A
Seymour, M
Homerin, M
Hmissi, A
Cassidy, J
Boni, C
Cortes-Funes, H
Cervantes, A
Freyer, G
Papamichael, D
Le Bail, N
Louvet, C
Hendler, D
de Braud, F
Wilson, C
Morvan, F
Bonetti, A
Citation: A. De Gramont et al., Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer, J CL ONCOL, 18(16), 2000, pp. 2938-2947
Authors:
Freyer, G
Tranchand, B
Ligneau, B
Ardiet, C
Souquet, PJ
Court-Fortune, I
Riou, R
Rebattu, P
Boissel, JP
Trillet-Lenoir, V
Girard, P
Citation: G. Freyer et al., Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study, BR J CL PH, 50(4), 2000, pp. 315-324
Authors:
Freyer, G
Rougier, P
Bugat, R
Droz, JP
Marty, M
Bleiberg, H
Mignard, D
Awad, L
Herait, P
Culine, S
Trillet-Lenoir, V
Citation: G. Freyer et al., Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure, BR J CANC, 83(4), 2000, pp. 431-437
Authors:
Freyer, G
Dazord, A
Schlumberger, M
Conte-Devolx, B
Ligneau, B
Trillet-Lenoir, V
Lenoir, GM
Citation: G. Freyer et al., Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: A multicentric pilot-evaluation, ANN ONCOL, 10(1), 1999, pp. 87-95
Authors:
Tranchand, B
Amsellem, C
Chatelut, E
Freyer, G
Iliadis, A
Ligneau, B
Trillet-Lenoir, V
Canal, P
Lochon, I
Ardiet, CJ
Citation: B. Tranchand et al., A limited-sampling strategy for estimation of etoposide pharmacokinetics in cancer patients, CANC CHEMOT, 43(4), 1999, pp. 316-322
Authors:
Kuhn, C
Freyer, G
Weikard, R
Goldammer, T
Schwerin, M
Citation: C. Kuhn et al., Detection of QTL for milk production traits in cattle by application of a specifically developed marker map of BTA6, ANIM GENET, 30(5), 1999, pp. 333-340
Citation: G. Freyer et P. Romestaing, The respective roles of radiotherapy and chemotherapy in the adjuvant treatment of breast cancer: theoretical value and feasibility of chemoradiation, CONCOMITANT CHEMORADIATION: CURRENT STATUS AND FUTURE, 1999, pp. 178-190